Weiping Zou
#52,914
Most Influential Person Now
Professor of Surgery
Weiping Zou's AcademicInfluence.com Rankings
Weiping Zoumedical Degrees
Medical
#1172
World Rank
#1486
Historical Rank
Surgery
#116
World Rank
#156
Historical Rank
Download Badge
Medical
Weiping Zou's Degrees
- Doctorate Medicine Tsinghua University
- PhD Immunology Tsinghua University
Why Is Weiping Zou Influential?
(Suggest an Edit or Addition)According to Wikipedia, Weiping Zou is the Charles B. de Nancrede Professor of Pathology, Immunology, Biology, and Surgery at the University of Michigan. He is a scientist noted for his work regarding understanding the nature of human tumor immune responses and developing mechanism-informed combination therapies for cancer. He has developed an international reputation in human tumor immunosuppressive mechanisms in the tumor microenvironment.
Weiping Zou's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival (2004) (4985)
- Understanding the tumor immune microenvironment (TIME) for effective therapy (2018) (2583)
- Regulatory T cells, tumour immunity and immunotherapy (2006) (2084)
- Immunosuppressive networks in the tumour environment and their therapeutic relevance (2005) (2034)
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations (2016) (1629)
- Inhibitory B7-family molecules in the tumour microenvironment (2008) (1412)
- Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity (2003) (1241)
- Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy (2017) (1202)
- Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy (2017) (1071)
- CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy (2019) (1049)
- Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 (2021) (811)
- Epigenetic silencing of Th1 type chemokines shapes tumor immunity and immunotherapy (2015) (795)
- Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. (2009) (734)
- B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma (2006) (702)
- Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells (2001) (687)
- TH17 cells in tumour immunity and immunotherapy (2010) (541)
- T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. (2013) (535)
- Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. (2014) (463)
- Cancer nanomedicine for combination cancer immunotherapy (2019) (454)
- Induction of IL-17+ T Cell Trafficking and Development by IFN-γ: Mechanism and Pathological Relevance in Psoriasis1 (2008) (450)
- Bone Marrow Is a Reservoir for CD4+CD25+ Regulatory T Cells that Traffic through CXCL12/CXCR4 Signals (2004) (441)
- Cutting Edge: Th17 and Regulatory T Cell Dynamics and the Regulation by IL-2 in the Tumor Microenvironment1 (2007) (432)
- Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor (2017) (427)
- CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. (2005) (419)
- Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. (2005) (404)
- Endogenous IL-17 contributes to reduced tumor growth and metastasis. (2009) (384)
- Tim‐3/galectin‐9 signaling pathway mediates T‐cell dysfunction and predicts poor prognosis in patients with hepatitis B virus‐associated hepatocellular carcinoma (2012) (383)
- Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. (2019) (375)
- Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer (2018) (360)
- Classification of current anticancer immunotherapies (2014) (357)
- Regulatory T-cell compartmentalization and trafficking. (2006) (353)
- Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies (2015) (339)
- Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis. (2007) (334)
- Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. (2013) (332)
- Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. (2011) (330)
- Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions. (2009) (308)
- Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. (2007) (307)
- Cutting Edge: Induction of B7-H4 on APCs through IL-10: Novel Suppressive Mode for Regulatory T Cells1 (2006) (300)
- IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L. (2014) (300)
- Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction (2015) (298)
- Dendritic Cell Subsets Differentially Regulate Angiogenesis in Human Ovarian Cancer (2004) (292)
- Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer (2016) (292)
- LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern. (2016) (291)
- Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. (2010) (281)
- Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination (2021) (268)
- Regulatory T Cells in Ovarian Cancer: Biology and Therapeutic Potential (2005) (256)
- IL-17+ Regulatory T Cells in the Microenvironments of Chronic Inflammation and Cancer (2011) (249)
- Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells (2012) (247)
- Human TH17 Cells Are Long-Lived Effector Memory Cells (2011) (245)
- Decreased dietary fiber intake and structural alteration of gut microbiota in patients with advanced colorectal adenoma. (2013) (244)
- Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer. (2014) (240)
- Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression. (2018) (239)
- NF-κB inhibits osteogenic differentiation of mesenchymal stem cells by promoting β-catenin degradation (2013) (238)
- Bone marrow and the control of immunity (2011) (237)
- Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression (2018) (227)
- Deciphering the role of Th17 cells in human disease. (2011) (218)
- Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer. (2018) (209)
- LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc (2019) (195)
- Cutting Edge: Opposite Effects of IL-1 and IL-2 on the Regulation of IL-17+ T Cell Pool IL-1 Subverts IL-2-Mediated Suppression1 (2007) (190)
- FOXP3 defines regulatory T cells in human tumor and autoimmune disease. (2009) (188)
- PRC2 Epigenetically Silences Th1-Type Chemokines to Suppress Effector T-Cell Trafficking in Colon Cancer. (2016) (183)
- Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling. (2016) (180)
- Cancer SLC43A2 alters T cell methionine metabolism and histone methylation (2020) (179)
- Th17 cells in cancer: help or hindrance? (2011) (174)
- TH17 cells in tumour immunity and immunotherapy (2011) (165)
- ARID1A-mutated ovarian cancers depend on HDAC6 activity (2017) (160)
- Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma. (2007) (159)
- Macrophage-Derived Dendritic Cells Have Strong Th1-Polarizing Potential Mediated by β-Chemokines Rather Than IL-121 (2000) (151)
- Interleukin-10 ablation promotes tumor development, growth, and metastasis. (2012) (138)
- Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer (2020) (126)
- Prognostic significance of regulatory T cells in tumor (2010) (122)
- IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment. (2017) (121)
- Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity (2016) (121)
- Consensus nomenclature for CD8+ T cell phenotypes in cancer (2015) (118)
- Dual biological effects of the cytokines interleukin-10 and interferon-γ (2011) (118)
- Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy. (2019) (116)
- Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer (2012) (116)
- Autophagy in tumour immunity and therapy (2021) (115)
- Myeloid cells in hepatocellular carcinoma (2015) (113)
- The Role of Tumor Microenvironment in Cancer Immunotherapy. (2017) (112)
- CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. (2022) (96)
- Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression (2017) (91)
- Biological and pathological activities of interleukin-22 (2016) (90)
- Inhibition of JAK2/STAT3 signalling induces colorectal cancer cell apoptosis via mitochondrial pathway (2012) (86)
- Targeting regulatory T cells (2012) (85)
- Epigenetic driver mutations in ARID1A shape cancer immune phenotype and immunotherapy. (2020) (84)
- Unequal prognostic potentials of p53 gain-of-function mutations in human cancers associate with drug-metabolizing activity (2014) (83)
- Cutting Edge: IFN-γ Enables APC to Promote Memory Th17 and Abate Th1 Cell Development1 (2008) (80)
- Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy. (2020) (72)
- MiR-194 Deregulation Contributes To Colorectal Carcinogenesis via Targeting AKT2 Pathway (2014) (70)
- Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines. (2009) (69)
- Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta. (2008) (68)
- Suppression of FIP200 and autophagy by tumor-derived lactate promotes naïve T cell apoptosis and affects tumor immunity (2017) (67)
- Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies (2015) (64)
- LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy (2021) (63)
- Erratum: TH 17 cells in tumour immunity and immunotherapy (Nature Reviews Immunology (2010) 10 (248-256)) (2011) (63)
- OCT1 is a determinant of synbindin-related ERK signalling with independent prognostic significance in gastric cancer (2014) (62)
- Role of T Cell TGFβ Signaling and IL-17 in Allograft Acceptance and Fibrosis Associated with Chronic Rejection1 (2009) (60)
- Elf3 drives β-catenin transactivation and associates with poor prognosis in colorectal cancer (2014) (57)
- MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8 (2014) (57)
- ArhGAP30 promotes p53 acetylation and function in colorectal cancer (2014) (56)
- Cutting edge: IFN-gamma enables APC to promote memory Th17 and abate Th1 cell development. (2008) (56)
- Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity. (2021) (55)
- Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity (2016) (55)
- Tissue-resident memory T cells in tumor immunity and immunotherapy (2021) (54)
- Toxoplasma gondii-Infected Human Myeloid Dendritic Cells Induce T-Lymphocyte Dysfunction and Contact-Dependent Apoptosis (2002) (53)
- Spatial and phenotypic immune profiling of metastatic colon cancer. (2018) (53)
- CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy (2019) (52)
- The Chemokine SDF‐1/CXCL12 Contributes to T Lymphocyte Recruitment in Human Pre‐ovulatory Follicles and Coordinates with Lymphocytes to Increase Granulosa Cell Survival and Embryo Quality (2005) (52)
- A Crucial Role for Host APCs in the Induction of Donor CD4+CD25+ Regulatory T Cell-Mediated Suppression of Experimental Graft-versus-Host Disease (2010) (51)
- TLR2 Mediates Helicobacter pylori–Induced Tolerogenic Immune Response in Mice (2013) (50)
- Reciprocal regulation of plasmacytoid dendritic cells and monocytes during viral infection (2001) (47)
- Th17 cells have stem cell-like features and promote long-term immunity (2012) (46)
- TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation (2017) (44)
- Autophagic adaptation to oxidative stress alters peritoneal residential macrophage survival and ovarian cancer metastasis (2020) (42)
- Stanniocalcin 1 is a phagocytosis checkpoint driving tumor immune resistance. (2021) (40)
- Antigen-Presenting Cell (APC) Subsets in Ovarian Cancer (2011) (39)
- TMEFF2 Deregulation Contributes to Gastric Carcinogenesis and Indicates Poor Survival Outcome (2014) (37)
- Retracted: Role of STAT3 and vitamin D receptor in EZH2‐mediated invasion of human colorectal cancer (2013) (37)
- Interferons α, β, γ each inhibit hepatitis C virus replication at the level of internal ribosome entry site‐mediated translation (2005) (37)
- Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice. (2019) (36)
- Synbindin in extracellular signal-regulated protein kinase spatial regulation and gastric cancer aggressiveness. (2013) (36)
- Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease (2011) (34)
- Effects of Tumor Irradiation on Host T-Regulatory Cells and Systemic Immunity in the Context of Adoptive T-Cell Therapy in Mice (2013) (32)
- Regulatory T cells: a new frontier in cancer immunotherapy. (2008) (31)
- CD4+ tissue-resident memory T-cells expand and are a major source of mucosal tumor necrosis factor α in active Crohn's Disease. (2019) (29)
- IFNγ signaling integrity in colorectal cancer immunity and immunotherapy (2021) (28)
- Th22 cells control colon tumorigenesis through STAT3 and Polycomb Repression complex 2 signaling (2016) (27)
- Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate Cancer (2021) (26)
- Regulatory T Cells in Human Ovarian Cancer (2012) (26)
- Elevated Serum IL-8 Is Associated with the Presence of Hepatocellular Carcinoma and Independently Predicts Survival (2012) (26)
- Drugs Designed To Inhibit Human p38 Mitogen-Activated Protein Kinase Activation Treat Toxoplasma gondii and Encephalitozoon cuniculi Infection (2007) (25)
- Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma (2016) (25)
- Mechanistic insights into cancer immunity and immunotherapy (2018) (25)
- In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo. (2018) (24)
- miR-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer. (2018) (24)
- T Cells and Costimulation in Cancer (2013) (24)
- Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors (2020) (24)
- Plasmacytoid Dendritic Cells Induce CD 8 + Regulatory T Cells In Human Ovarian Carcinoma (2005) (23)
- The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated anti-tumor immunity (2021) (22)
- The B7 Homologues and their Receptors in Hematologic Malignancies (2012) (21)
- Loss of optineurin drives cancer immune evasion via palmitoylation-dependent IFNGR1 lysosomal sorting and degradation. (2021) (20)
- Long Noncoding RNA GAPLINC Regulates CD 44-Dependent Cell Invasiveness and Associates with Poor Prognosis of Gastric Cancer (2014) (19)
- Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation. (2005) (19)
- Modeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responses. (2009) (18)
- Blocking HDACs boosts regulatory T cells (2007) (17)
- FOXP 3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease (2009) (17)
- Immunotherapy in Ovarian Cancer. (2019) (17)
- Mathematical Modeling of the Metastatic Colorectal Cancer Microenvironment Defines the Importance of Cytotoxic Lymphocyte Infiltration and Presence of PD-L1 on Antigen Presenting Cells (2019) (16)
- PRC 2 Epigenetically Silences Th 1-Type Chemokines to Suppress Effector T-Cell Traf fi cking in Colon Cancer (2015) (16)
- Human Naive T Cells Express Functional CXCL8 and Promote Tumorigenesis (2018) (15)
- Tumor-infiltrating T cells in epithelial ovarian cancer: predictors of prognosis and biological basis of immunotherapy. (2018) (14)
- CD8+ T Cells in Immunotherapy, Radiotherapy, and Chemotherapy (2018) (14)
- Tracking Macrophage Infiltration in a Mouse Model of Pancreatic Cancer with the Positron Emission Tomography Tracer [11C]PBR28. (2018) (14)
- A 16q22.1 variant confers susceptibility to colorectal cancer as a distal regulator of ZFP90 (2019) (13)
- Cancer Immunotherapy Principles and Practice (2018) (13)
- Chemokines and cellular plasticity of ovarian cancer stem cells (2015) (12)
- Citrobacter rodentium Induces Tissue-Resident Memory CD4+ T Cells (2019) (12)
- Metabolism drives macrophage heterogeneity in the tumor microenvironment (2022) (11)
- Phenotype and tissue distribution of CD28H+ immune cell subsets (2017) (10)
- RORγ Agonists Enhance the Sustained Antitumor Activity through Intrinsic Tc17 Cytotoxicity and Tc1 Recruitment (2019) (9)
- Denileukin diftitox depletes regulatory T cells without clinical benefit in advanced stage epithelial ovarian carcinoma (VAC3P.945) (2014) (8)
- Optimization, Design and Avoiding Pitfalls in Manual Multiplex Fluorescent Immunohistochemistry. (2019) (7)
- Inhibitory B7 family members in human ovarian carcinoma. (2008) (6)
- OXPHOS promotes apoptotic resistance and cellular persistence in TH17 cells in the periphery and tumor microenvironment (2022) (6)
- Response: Endogenous IL-17, tumor growth, and metastasis (2010) (5)
- Immune regulation in the tumor microenvironment and its relevance in cancer therapy (2021) (5)
- A PHD in immunosuppression: oxygen-sensing pathways regulate immunosuppressive Tregs. (2019) (5)
- A phase II trial of denileukin diftitox to treat refractory advanced-stage ovarian cancer. (2006) (5)
- Novel tumor immunotherapy: Targeting dysfunctional antigen presenting cells. (2005) (4)
- Role of STAT 3 and vitamin D receptor in EZH 2-mediated invasion of human colorectal cancer (2013) (4)
- Dendritic cells are stressed out in tumor (2015) (4)
- Cancer SLC43A2 alters T cell methionine metabolism and histone methylation (2020) (4)
- IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer (2021) (4)
- 1 Interleukin ( IL )-10 ablation promotes tumor development , growth and metastasis (2011) (4)
- 290 DEPLETING REGULATORY T CELLS IS ASSOCIATED WITH IMPROVED IMMUNITY AND TUMOR CLEARANCE IN HUMAN CANCER (2005) (4)
- CHAPTER 7 – Isolation, culture and propagation of dendritic cells (2001) (4)
- Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy. (2023) (4)
- T lymphocytes to IDO+ cells: check. (2011) (4)
- Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis (2020) (4)
- Immune Escape: Immunosuppressive Networks (2007) (3)
- Phase Ib/II study of durvalumab and guadecitabine in advanced kidney cancer Big Ten Cancer Research Consortium BTCRC GU16-043. (2021) (3)
- Cytidine Deaminase APOBEC3A Regulates PD-L1 Expression in Cancer Cells in a JNK/c-JUN-Dependent Manner (2021) (3)
- Depletion of androgen receptor (AR) in mesenchymal stem cells (MSCs) inhibits induction of CD4+CD25+FOX3+ regulatory T (Treg) cells via androgen TGF-β interaction (2015) (3)
- Manipulating T regulatory cells in cancer immunotherapy (2006) (3)
- RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity (2015) (3)
- OCT 1 is a determinant of synbindin-related ERK signalling with independent prognostic signi fi cance in gastric cancer (2014) (3)
- Induction of T-helper-17-cell-mediated anti-tumour immunity by pathogen-mimicking polymer nanoparticles (2022) (3)
- Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating Cancer. (2021) (3)
- Regulation of immune-related diseases by multiple factors of chromatin, exosomes, microparticles, vaccines, oxidative stress, dormancy, protein quality control, inflammation and microenvironment: a meeting report of 2017 International Workshop of the Chinese Academy of Medical Sciences (CAMS) Initia (2017) (3)
- Nine lives for TH9s? (2012) (2)
- Long non-coding RNA GAPLINC regulates CD 44-dependent cell invasiveness and associates with poor prognosis of gastric cancer (2014) (2)
- Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors (2023) (2)
- Regulatory T Cells in Tumor Immunity (2016) (2)
- Uncovering the Immunoregulatory Function and Therapeutic Potential of the PD-1/PD-L1 Axis in Cancer (2021) (2)
- DOT1L affects colorectal carcinogenesis via altering T cell subsets and oncogenic pathway (2022) (2)
- IFNγ signaling integrity in colorectal cancer immunity and immunotherapy (2021) (2)
- Macrophage-Derived Dendritic Cells Have Strong Th1-Polarizing Potential Mediated by b-Chemokines Rather (2000) (2)
- Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade (2017) (2)
- Pathological Relevance in Psoriasis : Mechanism and γ Development by IFN-T Cell Trafficking and + Induction of IL-17 Welling (2008) (2)
- Abstract 4153: Therapeutic targeting autophagy to sensitize cancer immunotherapy in various cancer types (2019) (1)
- Cancer epigenetics and effector T cells in immunotherapy and chemotherapy. (2017) (1)
- Abstract 315: Immune cells promote hepatocellular carcinoma stemness phenotype (2012) (1)
- Response to Comment on “Cutting Edge: Induction of B7-H4 on APCs through IL-10: Novel Suppressive Mode for Regulatory T Cells” (2007) (1)
- Th17 Cells in Cancer (2013) (1)
- Introduction to the special issue-Barriers and opportunities to cancer immunotherapy in the tumor immune microenvironment. (2020) (1)
- TH17 Cells in the Tumor Micro-environment (2011) (1)
- Reply to 'VLA-5 and transendothelial migration' (2002) (1)
- Abstract LB-259: Interferon-α enhances clinical benefits of regulatory T cell depletion in ovarian cancer through direct T cell effects and by inducing bystander IL-6 (2014) (1)
- Rewiring regulatory T cells for tumour killing (2019) (1)
- Amendment history : Erratum ( April 2018 ) Host expression of PD-L 1 determines efficacy of PD-L 1 pathway blockade – mediated tumor regression (2018) (1)
- Biological and pathological activities of interleukin-22 (2016) (1)
- Interferon-α augments the clinical efficacy of regulatory T cell depletion in ovarian cancer through direct and indirect T cell effects (VAC3P.941) (2014) (1)
- Novel RORgamma agonists enhance anti-tumor activity of adoptive T cell therapy (TUM2P.1010) (2015) (1)
- Phase II trial of Ontak to deplete regulatory T cells in treatment-refractory stage III/IV ovarian cancer (2006) (1)
- Abstract SY17-01: Metabolic impact on immune cell subsets in the tumor microenvironment and its therapeutic relevance (2018) (1)
- Oxidative phosphorylation controls regulatory T cell suppressor activity of in the tumor microenvironment (2016) (1)
- Biology of Human Tumors TMEFF 2 Deregulation Contributes to Gastric Carcinogenesis and Indicates Poor Survival Outcome (2014) (1)
- 293 Targeting HCV NS3 to dendritic cells (DC) via DC-binding peptides induces potent T cell immunity I in vivo (2003) (1)
- A forced marriage of IL-2 and PD-1 antibody nurtures tumor-infiltrating T cells (2022) (1)
- T Cell and Antigen-Presenting Cell Subsets in the Tumor Microenvironment (2013) (1)
- Therapeutic Targeting Regulatory T Cells in Tumor (2013) (1)
- SDF-1, DC1/DC2, and Tumor Angiogenesis (2005) (0)
- Abstract 4273: RORγ agonists as a novel immunotherapy approach for cancer (2015) (0)
- Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination (2021) (0)
- Understanding the tumor immune microenvironment (TIME) for effective therapy (2018) (0)
- T Cell Fate in the Tumor Microenvironment (2015) (0)
- Epigenetic silencing of Th1-type chemokines dictates effector T cell tumor trafficking and predicts patient outcome (TUM7P.1019) (2015) (0)
- Relevance of host and tumor PD-L1 in PD-L1 pathway blockade (2018) (0)
- Tracking macrophage infiltration in a mouse model of pancreas cancer with the PET tracer [11C]PBR28 (2018) (0)
- The immune system and cancer stemness cross-talk can predict therapeutic response and patient outcome (P3030) (2013) (0)
- The epigenetic cross-talk between tumor cells and immune microenvironment in colorectal cancer (2016) (0)
- Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach (2014) (0)
- Abstract 4078: EZH2 marks polyfunctional memory T cells and controls tumor immunity (2014) (0)
- Abstract B19: Targeting ATM to sensitize pancreatic cancer to immunotherapy and radiotherapy (2019) (0)
- FIP200 targets Ago2 and mitochondria in naive T cells to control tumor immunity (2016) (0)
- IL-22 induces colon cancer proliferation through STAT3 and PRC2 signaling (TUM10P.1036) (2015) (0)
- Novel, synthetic RORgamma agonist compounds as a potential anti-cancer approach (2014) (0)
- Effector CD8+ T cells abrogate fibroblasts-mediated chemoresistance in ovarian cancer (TUM2P.1007) (2015) (0)
- Mo1927 – Citrobacter Rodentium Induces Cd4+ Tissue Resident Memory T-Cells that Expand with Re-Challenge (2019) (0)
- CD8+ T cells regulate tumor ferroptosis by targeting the system xc− during cancer immunotherapy (2019) (0)
- 0270: Ontak: a Potential Novel Treatment of Recurrent Ovarian Cancer (2006) (0)
- QS157. Antigen Presenting Cell B7-H1 and T Cell PD-1 are Increased in Human Hepatocellular Carcinoma: Evidence for Increased Immune Regulation (2009) (0)
- Modeling Dynamic Fluctuations in Type 1 Diabetes Progression: Quantifying β -cell variation after the appearance of islet-specific autoimmune responses (2015) (0)
- Erratum: Role of STAT3 and Vitamin D receptor in EZH2-mediated invasion of human colorectal cancer (Journal of Pathology (2013) 230 (277-290) DOI: 10.1002/path.4179) (2016) (0)
- Tumor Microenvironment Dynamics and the Regulation by IL-2 in the Cutting Edge: Th17 and Regulatory T Cell (2007) (0)
- 0029: Treg Cells, B7-H41 Macrophages and Their Relationship with Survival in Ovarian Cancer (2006) (0)
- Regulatory T Cells and Tumour Immunotherapy (2008) (0)
- Th22 cells shape colorectal cancer stemness via epigenetic regulation (TUM2P.877) (2014) (0)
- Immune regulation in the tumor microenvironment and its relevance in cancer therapy (2021) (0)
- Molecular and Cellular Pathobiology Long Noncoding RNA GAPLINC Regulates CD 44-Dependent Cell Invasiveness and Associates with Poor Prognosis of Gastric Cancer (2014) (0)
- Final results of phase Ib/II study of durvalumab and guadecitabine in advanced clear cell renal cell carcinoma (ccRCC) and biomarker analysis. (2023) (0)
- Abstract 2036: Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors (2023) (0)
- Abstract IA18: Metabolic impact on cancer immunity (2020) (0)
- OXPHOS Promotes Apoptotic Resistance and Persistence in TH17 cells (2021) (0)
- 2082 1 7 F E B R U a R Y 2 0 1 1 I V O L U M E 1 1 7 , N U M B E R 7 Blood (2011) (0)
- 219 DEPLETING REGULATORY T CELLS IS ASSOCIATED WITH IMPROVED IMMUNITY AND TUMOR CLEARANCE IN HUMAN CANCER (2005) (0)
- Abstract 2450: Resistance of CD44+ hepatocellular carcinoma cancer stem cellsto immune effector responses (2011) (0)
- T-Regulatory Cell Manipulation in Tumor Immunotherapy (2007) (0)
- 524 Tim-4+ resident macrophages impair anti-tumor immunity in the serous body cavities By sequestering viable and cytotoxic CD8+ T cells expressing high levels of phosphatidylserine (2020) (0)
- Abstract A08: Resolving STING-mediated tumor immune microenvironment shift at single-cell resolution (2020) (0)
- Glycolysis promotes MDSCs and cancer stemness through the interaction between Sirt1 and C/EBPb (2016) (0)
- Relationship Between Th17 and Regulatory T Cells in the Tumor Environment (2012) (0)
- Mo1877 – Tumor Necrosis Factor α and Il-17A Producing Cd4+ Tissue Resident Memory T-Cells are Expanded in Crohn’s and are Inhibited by the Anti-Inflammtory Microbial Metabolite Butyrate (2019) (0)
- Abstract POSTER-BIOL-1332: Molecular, cellular and clinical interaction between MDSC and ovarian cancer stemness (2015) (0)
- Abstract 3442: Multimodal mapping of the immune landscape in human pancreatic cancer (2020) (0)
- Immune biomarkers in ovarian cancer (2007) (0)
- Abstract PR-004: Radiation modulates hepatic siphoning of T cells to improve immunotherapy efficacy (2021) (0)
- Abstract IA4: T cell subsets in the tumor microenvironment. (2013) (0)
- 23 INVITED T regs in cancer (2006) (0)
- Single-arm phase ib/II study of durvalumab and guadecitabine in advanced kidney cancer (NCT03308396). (2018) (0)
- Abstract IA28: Cancer epigenetic and metabolic mechanisms controlling immunotherapy and chemotherapy (2016) (0)
- IL-22 Promotes Pancreatic Cancer Tumorigenesis through Induction of Stemness and Epithelial to Mesenchymal Transition (2017) (0)
- Use of [11C]PBR28 to localize and quantify tumor associated macrophages in pancreas cancer (TUM6P.1008) (2015) (0)
This paper list is powered by the following services:
Other Resources About Weiping Zou
What Schools Are Affiliated With Weiping Zou?
Weiping Zou is affiliated with the following schools:
